StockData
Telix Pharmaceuticals Ltd logo

Telix Pharmaceuticals Ltd (TLX) stock

TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 20, 2026Score 3/30
$8.96+0.11 (+1.19%)

Close on Nov 18, 2026Market cap $3.04BP/E –Yield –

Telix Pharmaceuticals net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was -$7.13M, down 121.2% from the year before.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$7.13M-121.2%
FY2024Dec 31, 2024$33.69M+700.5%
FY2023Dec 31, 2023$4.21M–

More Telix Pharmaceuticals figures

See a number that looks wrong?